Keybank National Association OH Invests $393,000 in HealthEquity, Inc. (NASDAQ:HQY)

Keybank National Association OH bought a new stake in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 4,092 shares of the company's stock, valued at approximately $393,000.

A number of other hedge funds have also recently modified their holdings of HQY. Smartleaf Asset Management LLC boosted its position in HealthEquity by 34.3% in the 4th quarter. Smartleaf Asset Management LLC now owns 384 shares of the company's stock valued at $37,000 after buying an additional 98 shares during the period. Louisiana State Employees Retirement System boosted its holdings in shares of HealthEquity by 0.4% in the fourth quarter. Louisiana State Employees Retirement System now owns 24,200 shares of the company's stock valued at $2,322,000 after purchasing an additional 100 shares during the period. Oregon Public Employees Retirement Fund grew its stake in HealthEquity by 0.6% in the fourth quarter. Oregon Public Employees Retirement Fund now owns 17,776 shares of the company's stock worth $1,706,000 after purchasing an additional 100 shares in the last quarter. State of Michigan Retirement System grew its stake in HealthEquity by 0.5% in the fourth quarter. State of Michigan Retirement System now owns 20,722 shares of the company's stock worth $1,988,000 after purchasing an additional 100 shares in the last quarter. Finally, Raymond James Trust N.A. increased its holdings in HealthEquity by 4.8% during the 3rd quarter. Raymond James Trust N.A. now owns 2,905 shares of the company's stock worth $238,000 after purchasing an additional 132 shares during the period. Institutional investors own 99.55% of the company's stock.

Remove Ads

Insider Activity

In other HealthEquity news, Director Robert W. Selander sold 5,750 shares of the firm's stock in a transaction that occurred on Monday, February 10th. The shares were sold at an average price of $111.29, for a total transaction of $639,917.50. Following the completion of the transaction, the director now directly owns 78,219 shares of the company's stock, valued at approximately $8,704,992.51. This trade represents a 6.85 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Corporate insiders own 2.20% of the company's stock.

HealthEquity Stock Up 3.7 %

Shares of HQY stock traded up $3.44 during trading hours on Friday, reaching $97.41. 863,553 shares of the company's stock were exchanged, compared to its average volume of 655,955. HealthEquity, Inc. has a 1 year low of $65.01 and a 1 year high of $115.59. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.51. The stock has a market cap of $8.44 billion, a PE ratio of 89.37, a PEG ratio of 1.60 and a beta of 0.62. The stock's fifty day moving average price is $105.68 and its two-hundred day moving average price is $94.93.

HealthEquity (NASDAQ:HQY - Get Free Report) last issued its quarterly earnings results on Monday, December 9th. The company reported $0.59 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.71 by ($0.12). HealthEquity had a net margin of 8.41% and a return on equity of 9.70%. During the same quarter last year, the business posted $0.40 EPS. Research analysts predict that HealthEquity, Inc. will post 2.32 EPS for the current year.

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on HQY shares. Mizuho began coverage on HealthEquity in a research report on Wednesday, December 4th. They set an "outperform" rating and a $126.00 price target on the stock. The Goldman Sachs Group started coverage on shares of HealthEquity in a research report on Friday, November 15th. They set a "neutral" rating and a $108.00 target price on the stock. Wells Fargo & Company upped their price target on shares of HealthEquity from $110.00 to $125.00 and gave the stock an "overweight" rating in a research report on Wednesday, February 26th. JMP Securities increased their price objective on shares of HealthEquity from $105.00 to $107.00 and gave the company a "market outperform" rating in a research note on Tuesday, December 10th. Finally, Barrington Research reissued an "outperform" rating and issued a $112.00 price objective on shares of HealthEquity in a research note on Friday. One investment analyst has rated the stock with a hold rating and twelve have given a buy rating to the company's stock. Based on data from MarketBeat.com, HealthEquity has a consensus rating of "Moderate Buy" and an average price target of $112.92.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.